A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
מצבים רפואיים
Idiopathic Pulmonary Fibrosis (IPF)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
UAB Lung Health Center, Birmingham, Alabama, United States
Contact: Principal Investigator (Tejaswini Kulkarni, MD)Cedars Sinai Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Tanzira Zaman, MD)Paradigm Clinical Research Centers, LLC, San Diego, California, United States
Contact: Principal Investigator (Daniel Jones, MD)National Jewish Health, Denver, Colorado, United States
Contact: Principal Investigator (Evans Fernandez Perez, MD)Yale University School of Medicine, New Haven, Connecticut, United States
Contact: Principal Investigator (Danielle Antin-Ozerkis, MD)Cleveland Clinic Florida, Weston, Florida, United States
Contact: Principal Investigator (David Zisman, MD)Henry Ford Health, Detroit, Michigan, United States
Contact: Principal Investigator (Asif M. Abdul Hameed, MD)The Lung Research Center, LLC, Chesterfield, Missouri, United States
Contact: Principal Investigator (Neil Ettinger, MD)University of Kansas Medical Center, Kansas City, Missouri, United States
Contact: Principal Investigator (Mark Hamblin, MD)University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Adam Souter)Contact: Principal Investigator (Jason Lobo, MD)Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Principal Investigator (Timothy Whelan, MD)El Paso Pulmonary Association, El Paso, Texas, United States
Contact: Principal Investigator (Carlo M. Hatem, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Mary Beth Scholand, MD)Westmead Hospital, Westmead, New South Wales, Australia
Contact: Principal Investigator (Laura Glenn, MD, PhD)Launceston Respiratory and Sleep Centre, Launceston, Tasmania, Australia
Contact: Principal Investigator (Collin Chia, MD)Instytut Gruzlicy i Chrob Pluc, Warsaw, Poland, Poland
Contact: Principal Investigator (Katarzyna Lewandowska, MD)Salus Aegroti Praktyka Lekarska dr n. med. Grzegorz Gąsior, Sosnowiec, Silesian Voivodeship, Poland
Contact: Principal Investigator (Grzegorz Gasior, MD, PhD)Royal Papworth Hospital, Trumpington, Cambridge, United Kingdom
Contact: Principal Investigator (Helen Parfrey, MD)Royal Devon and Exeter Hospital, Exeter, Devon, United Kingdom
Contact: Principal Investigator (Michael Gibbons, MD)Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom
Contact: Principal Investigator (Manjit Cartlidge, MD)Royal Brompton Hospital, London, United Kingdom
Contact: Principal Investigator (Philip Molyneaux, MD)